SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ajanta Pharma

Ajanta Pharma

BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 16:00
1703.55
-10.35 (-0.6%)
VOLUME 17,591
LIVE
NSE
Feb 23, 15:59
1706.35
-8.75 (-0.51%)
VOLUME 198,460
News on Ajanta Pharma
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy, sell, hold: 5 stocks analysts recommend to watch out

10.05 am | 16 Feb 2017 |  Source: Moneycontrol.com

CLSA has retained its buy call on Phoenix Mills, with reduced target price at Rs 460 from Rs 479. It says company's lease income growth at malls is at...

Sell Ajanta Pharma, Engineers India: Mitessh Thakkar 

2.50 pm | 15 Feb 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com suggests selling Ajanta Pharma and Engineers India....

Invest in private sector banks for long-term, says Dipan Mehta 

9.54 am | 10 Feb 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Dipan Mehta, Member of BSE & NSE shared his readings and outlook on specific stocks and sector....

Ajanta Pharma gets USFDA observation for Paithan facility

9.50 am | 10 Feb 2017 |  Source: PTI

"This is to inform that our Paithan facility was recently inspected by the US FDA and we are issued one procedural related 483," Ajanta Pharma said in...

Buy Reliance Capital, Ajanta Pharma, Simplex Infra: Gujral 

11.32 am | 09 Feb 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com recommends buying Reliance Capital, Ajanta Pharma and Simplex Infra....

Ajanta Pharma: Updates on USFDA inspection of Paithan facility

10.49 am | 09 Feb 2017 |  Source: Moneycontrol.com

Ajanta Pharma Ltd has informed BSE that the Company's Paithan facility was recently inspected by US FDA and the Company has issued one procedural rela...

Sell Ajanta Pharma, Ceat: buy Bata India: Sudarshan Sukhani 

12.24 pm | 31 Jan 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Ajanta Pharma and Ceat while one can buy Bata India....

Buy Ajanta Pharma; target of Rs 1960: ICICI Direct

1.24 pm | 27 Jan 2017 |  Source: Moneycontrol.com

ICICI Direct is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1960 in its research report dated January 2...

1
Quick Links for Ajanta Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.